English
Company News
High-end pharmaceutical excipients: Strengthening the foundation and empowering preparationsHigh-end pharmaceutical excipients also play an indispensable and crucial role in the modern pharmaceutical industry. It is by no means a simple auxiliary ingredient, but has a decisive influence on key properties such as the stability, solubility, r
Created on 09.02Specialty active pharmaceutical ingredients: Innovation leads the way, quality firstSpecialty apis, as the backbone of the API field, are significantly different from traditional bulk apis. It focuses on drugs whose patents have not yet expired or those with special therapeutic needs. The research and development and manufacturing a
Created on 09.02The supply chain reorganization of multinational pharmaceutical companies has brought favor to Chinese CDMO enterprisesThe supply chains of multinational pharmaceutical companies are undergoing a profound reorganization. Chinese CDMO (Contract Development and Manufacturing Organization) enterprises, with their strong technical strength, cost-effectiveness and continu
Created on 09.02As competition in the Indian market intensifies, Chinese enterprises are focusing on high-barrier intermediates to break throughFacing the price competition from India in the field of generic drug intermediates, Chinese enterprises have turned to high-tech barrier products in search of breakthroughs. For instance, Shengnuo Biotech focuses on GLP-1 weight loss drug intermediat
Created on 09.02Our technological advantagesOur technological advantages
Synthesis of chiral compounds, ultra-low temperature reactions, anhydrous and oxygen-free reactions, hydrogenation reactions, reduction alkylation, Friedel-alkyl/acyl reactions, substitution reactions
Patents: 50 inventio
Created on 09.02Information disclosure on conducting clean production auditsCompany profile and environmental protection status
Chuzhou Qingyun Pharmaceutical Co., Ltd. is an enterprise specializing in the research and development, production and trade of active pharmaceutical ingredients and pharmaceutical intermediates. Th
Created on 09.02The Ministry of Science and Technology has issued the "Special Plan for Biotechnology Innovation during the 13th Five-Year Plan Period".On May 10th, the official website of the Ministry of Science and Technology released a message. In accordance with the overall arrangements of the "Outline of the 13th Five-Year Plan for National Economic and Social Development of the People's Republ
Created on 09.02Introduction to Anhui Qingyun Pharmaceutical Co., LTDChuzhou Qingyun Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing enterprise specializing in the research and development, production and trade of active pharmaceutical ingredients and pharmaceutical intermediates. The company was establishe
Created on 09.02Phone
Mail